Skip Nav Destination
1-20 of 35
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
CAR T Cells Derived from Healthy Mice Lead to Cytokine Release Syndrome (CRS) in the TCL1 Chronic Lymphocytic Leukemia Model; Mice with CLL Treated with Acalabrutinib or Ibrutinib Have Improved CAR T Cell Function without Increasing the Cytokines of CRS
Blood (2019) 134 (Supplement_1): 249.
Elevated IL-1Ra Levels in the Stem Cell Product Is Associated with the Development of Engraftment Syndrome Following Autologous Stem Cell Transplantation for the Treatment of Multiple Myeloma and Lymphoma
Stacey L. Fanning, PhD, Kira Goldgirsh, MS, Dante B. Descalzi-Montoya, PhD, Rena Feinman, PhD, David S Siegel, MD PhD, Noa Biran, MD, David H. Vesole, MD PhD, Andre Goy, MD, Tatyana A. Feldman, MD, Lori A. Leslie, MD, Scott D. Rowley, MD, Alan P Skarbnik, MD, Phyllis McKiernan, Melissa Baker, MSN, ANP, Michele L. Donato, MD, Robert Korngold, PhD
Blood (2018) 132 (Supplement 1): 2131.
Beyond Cytokine Storm: Optimizing Treatment Strategies to Target the Complex Interplay between CAR Mediated Inflammatory Response, Disseminated Intravascular Coagulation and Macrophage Activation Syndrome
Nirali N Shah, MD, Haneen Shalabi, DO, Bonnie Yates, RN, Eli Kane, Alina Dulau-Florea, MD, Anne Cullinane, BS, Cynthia Delbrook, RN, Michael Ombrello, MD, Amanda Ombrello, MD, Jay Nelson Lozier, MD PhD, Terry J. Fry, MD
Blood (2017) 130 (Supplement 1): 1277.
Development of Anti-IL-1R3 Monoclonal Antibodies for Treating Cancer and IL-1 Family-Mediated Inflammation
Jesper F Højen, MD, Megan K Taylor, Tania Azam, Stephan Fischer, Daniel A Pollyea, MD, Craig T Jordan, PhD, Charles A. Dinarello, MD
Blood (2016) 128 (22): 5224.
A Novel Mechanism of Cellular Activation Mediated By Antiphospholipid Antibody-Induced Extracellular Vesicles
Blood (2014) 124 (21): 100.
Clinical Presentation, Diagnosis, Treatment, and Outcome of Patients with Erdheim-Chester Disease: The Mayo Clinic Experience
Mithun Vinod Shah, MD PhD, Timothy G Call, MD, Carl C. Hook, MD, Patrick B. Johnston, MD PhD, Louis Letendre, MD, Joseph P. Colgan, MD, Animesh Pardanani, MBBS, PhD, Bart L. Clarke, MD, Karen L Grogg, MD, Ronald S. Go, MD
Blood (2014) 124 (21): 1405.
Role of Enhanced Microenvironmental Interleukin-1 (IL-1) Expression and Increased IL-1 Responsiveness in Persistence of Leukemia Stem Cells in TKI Treated CML Patients
Bin Zhang, PhD, YinWei Ho, Tinisha McDonald, B.S., Allen Lin, David S Snyder, MD, Vu N. Ngo, PhD, Tessa L. Holyoake, MD PhD, Ravi Bhatia, MD
Blood (2014) 124 (21): 4357.
Inhibition Of Microenvironmental Interleukin-1 Signaling Enhances TKI-Mediated Targeting Of Chronic Myelogenous Leukemia Stem Cells
Blood (2013) 122 (21): 512.
Interplay Between IL-1, IL-6 and IL-17 in IL-1 Receptor Antagonist (IL-1Ra) Treated Multiple Myeloma Patients
Blood (2012) 120 (21): 1874.
Disease Modeling and Drug Discovery Using Induced Pluripotent Stem Cells From CINCA Syndrome Patients
Takayuki Tanaka, MD, Akira Ohta, PhD, Masakatsu Yanagimachi, MD, PhD, Ryuta Nishikomori, MD, PhD, Toshio Heike, MD, PhD, Tatsutoshi Nakahata, MD, PhD, Shinya Yamanaka, MD, PhD, Megumu Saito, MD, PhD
Blood (2012) 120 (21): 4680.
Monocyte Shift to a Non-Classical CD14 dim /CD16 + Phenotype Correlates with Fetal Hemoglobin Levels in Sickle Cell Anemia Patients Treated with Hydroxyurea
Kleber Yotsumoto Fertrin, MD, PhD, Dulcinéia Martins Albuquerque, BSc, MSc, PhD, Carolina Lanaro, BSc, PhD, Carla Fernanda Franco-Penteado, PhD, Flavia Rubia Pallis, BSc, MSc, Sara T. Olalla Saad, MD, PhD, Fernando Ferreira Costa, MD, PhD
Blood (2012) 120 (21): 817.
α1 Anti-Trypsin (AAT) Mitigates Hematopoietic Injury and Enhances Bone Marrow Recovery After Total Body Irradiation (TBI)
Ekapun Karoopongse, MD, Sabina Janciauskiene, MD, Charles A. Dinarello, M.D., H. Joachim Deeg, A. Mario Q. Marcondes, MD, PhD
Blood (2012) 120 (21): 4142.
Hemophagocytic Lymphohistiocytosis in Adults: A Case Series of 30 Patients At a U.S. Tertiary Care Center
Blood (2012) 120 (21): 4681.
Long Term Follow-up of IL-1 Receptor Antagonist and Dexamethasone Phase II Clinical Trial in Patients with Smoldering/Indolent Myeloma Shows Improved Survival in Responsive Patients: Implications for Targeting Interleukin-1 Induced IL-6 Production and the Myeloma Proliferative Component
John A Lust, MD, PhD, Martha Q Lacy, MD, Steven R Zeldenrust, MD, PhD, Angela Dispenzieri, MD, Morie A Gertz, MD, Philip R. Greipp, MD, Thomas E. Witzig, MD, Shaji Kumar, MD, Laurie L. Moon-Tasson, BA, S. Vincent Rajkumar, MD, Kathleen A. Donovan, PhD
Blood (2011) 118 (21): 2945.
Study of Polymorphisms in DNMT3B promoter and IL-1 Ra in Childhood Idiopathic Thrombocytopenic Purpura.
Eftichia Stiakaki, MD, PhD, Marilena Lourou, Margarita Pesmatzoglou, MD, Vassilis Vasjiourakis, Helen Dimitriou, PhD, Maria Kalmanti, MD, PhD
Blood (2010) 116 (21): 3705.
Helen J Lachmann, MD, FRCP, Stephen Harding, PhD, Ashutosh Wechalekar, MD, FRCPath, Julian D Gillmore, E. Nicole Amft, MD, PhD, FRCP, Philip N Hawkins
Blood (2010) 116 (21): 3958.
Preliminary Evidences of Circulating Inflammatory Markers Associated with Symptom Development In Patients with Multiple Myeloma During Induction Therapy
Xin Shelley Wang, MD, MPH, James M Reuben, Ph.D., Bang-Ning Lee, Ph.D., PA-C, Robert Z. Orlowski, MD, PhD, Valen E Johnson, Ph.D., Jacqueline Joy, MS, CCRP, Matthew Galland, Evan Cohen, Gary M Mobley, MA, Ping Liu, MS, Tito R Mendoza, PhD, Charles Cleeland, PhD
Blood (2010) 116 (21): 4734.
Inflammasome activation in NADPH oxidase defective mononuclear phagocytes from patients with chronic granulomatous disease
Felix Meissner, Reinhard A. Seger, Despina Moshous, Alain Fischer, Janine Reichenbach, Arturo Zychlinsky
Blood (2010) 116 (9): 1570–1573.
Includes: Supplemental data
The Stage-Specific Effect of Interleukin-1 Beta (IL-1β) during Human Natural Killer Cell Development
Tiffany L Hughes, Michael Brian Becknell, M.D., Ph.D., Aharon Freud, M.D., Ph.D., Susan E Schmidt, Jianhua Yu, PhD, Charlene Mao, Mikhail Gavrilin, Ph.D., Mark Wewers, M.D., Michael A. Caligiuri, MD
Blood (2008) 112 (11): 3746.
Lia E. Perez, MD, Nancy Parquet, BS, Marina Molisano, BS, Ken Shain, Ph.D, Melisa Alsina, MD, Claudio Anasetti, MD, William Dalton, Ph.D. MD
Blood (2007) 110 (11): 3521.